Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SGRP @ $1.07: Lo-float, profitable & growing. Crowd starting on it now
SGRP @ $1.06: 3xs vol now. Lo-float, 07eps. Next CETX
SGRP @ $1.06: Getting found. Lo-float crowd on it. Orbit time
SGRP @ $1.06: Getting found. Lo-float crowd on it. Orbit time
SGRP @ $1.06: Lo-float crowd sending it right now. Next CETX
SGRP: Low float crowd starting to send it now. Next CETX
SGRP: Low float crowd starting to send it now. Next CETX
SGRP @ $1.05: Lo-floater. .07 EPS, 25% growth. Next rocket launch
SGRP @ $1.05: Lo-floater, .07 EPS, 25% growth. Next CETX
SGRP @ $1.05: Lo-floater, .07 EPS, 25% growth. Next CETX
SGRP @ $1.05: .07 EPS, low float, 25% growth. Next CETX
SGRP @ $1.05: .07 EPS, low float, 25% growth. Next CETX
Deflating now. Big seller drops VFRM under $1.00
No support at all. First one out saves their profits.
INSYQ: FDA approved Orphan Drug. NOT on news wires yet!.
Company PR due and it will be on all the news wires.
Free money for those that know this info right now.
FDA website link:
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=696519
INSYQ: FDA approval posted on FDA website. NOT on news wires yet!.
Company PR due and it will be on all the news wires.
Free money for those that know this info right now.
FDA website link:
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=696519
INSYQ: FDA approval posted on FDA website. NOT on news wires yet!.
Company PR due and it will be on all the news wires.
Free money for those that know this info right now.
FDA website link:
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=696519
INSYQ: FDA approves Orphan Drug Status for pot stock. NOT on wires yet.
Big news.
https://finance.yahoo.com/news/yield10-bioscience-expands-research-license-123000119.html
INSYQ: FDA approves Orphan Drug Status for epilepsy. NO PR YET!
LINK:
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=696519
INSYQ: FDA approves Orphan Drug Status for Epilepsy. NO PR YET!
First pot drug to get that FDA Status.
LINK:
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=696519
INSYQ granted FDA Orphan Drug Status for Epilepsy. NO PR YET!
First pot drug to get that FDA Status.
LINK:
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=696519
HEADS UP! INSYQ granted FDA Orphan Drug Status for Epilepsy. NO PR YET!
First pot drug to get that FDA Status.
LINK:
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=696519
HEADS UP! INSYQ granted FDA Orphan Drug Status for Epilepsy. NO PR YET!
First pot drug to get that FDA Status.
LINK:
https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=696519
VFRM: Reverse Split is next up. Solid opinion.
Can not have this many shares and hope to become a company that is taken seriously by investors.
R/S will be very painful for current share holders but help share holders that stay on sidelines and wait for VFRM to fall into. 60 to .80 cent area before the R/S.
Bought more CWBHF. Sold VFRM on pending Reverse Split
VFRM: Retest .80s ahead of Reverse Split pending news.
VFRM: Likely a 1-12 Reverse Split this week. Secondary too.
That would get them on to Nasdaq but screw every current investor now holding.
Almost every OTCBB headed to uplist does it.
Wait for drop below .80 om R/S news and consider rebuying
CWBHF competitor VFRM rumor: R/S & secondary offering.
Can only be good news for CWBHF
VFRM: 1 for 30 R/S is next & then secondary offering.
Every company that uplists does it and VFRM no different.
The money has been made here 100% to 500% for many investors.
Time to step back, let share price drop back to .60s area and buy back.
Float now 156M. ALL free trading. Get back in at .80s
SGRP @ .80s: Best of breed micro. Profitable, growing, unknown.
SGRP just posted a great profitable Earnings Report.
Action juts starting.
LINK:
https://finance.yahoo.com/news/spar-group-announces-financial-results-200500913.html
SGRP @ .80s: Best of breed micro. Profitable, growing, unknown.
SGRP just posted a great profitable Earnings Report.
Action juts starting.
LINK:
https://finance.yahoo.com/news/spar-group-announces-financial-results-200500913.html
SGRP @ .90s: Micro-floater. Great Q posted. Getting hot
SGRP @ .90s: Micro-floater. Profitable Q. Getting hot
SGRP @ .90s: Micro-floater. Profitable Q. Getting hot
VFRM: Share increase 93m to 156M. Reverse Split next
10-Q: Loss .01 cents. $1.2M loss for Q. R/S next.
10-Q out: .01 loss, $1.2M loss for Quarter. Not good
Float increased from 93M to 156M. Reverse Split next.
1 for 30 Reverse Split next.
Awful for investors
Own CWB. Also owned VFRM. Sold today on 63M share dilution.
Investors here would be smart to read the SEC filing posted today.
It is clear what VFRM is about to do.
The 63M shares just got released into the market.
Now, the logical move is a 1 for 30 Reverse Split.
The smart move is to go to the sidelines right now.
VFRM likely to move to a retest of .80 or so.
LINK: 63M shares of dilution:
https://ih.advfn.com/stock-market/USOTC/veritas-farms-inc-VFRM/stock-news/80530816/prospectus-filed-pursuant-to-rule-424b8-424b8
VFRM: 63M shares dilution. 1 for 30 Reverse Split next